Dexamethasone for cancer-related dyspnoea - Authors' reply

Affiliations

¹ Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: dhui@mdanderson.org.
² Cizik School of Nursing at UTHealth, The University of Texas Health Science Center at Houston, Houston, TX, USA.
³ Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Respiratory Services, Valley Regional Hospital, Claremont, NH, USA.
⁴ Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Comment

David Hui et al. Lancet Oncol. 2022 Dec.

. 2022 Dec;23(12):e526.

doi: 10.1016/S1470-2045(22)00699-4.

¹ Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: dhui@mdanderson.org.
² Cizik School of Nursing at UTHealth, The University of Texas Health Science Center at Houston, Houston, TX, USA.
³ Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Respiratory Services, Valley Regional Hospital, Claremont, NH, USA.
⁴ Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

No abstract available

Conflict of interest statement

Author declarations remain the same as in the original Article.

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.
Hui D, Puac V, Shelal Z, Dev R, Hanneman SK, Jennings K, Ma H, Urbauer DL, Shete S, Fossella F, Liao Z, Blumenschein G Jr, Chang JY, O'Reilly M, Gandhi SJ, Tsao A, Mahler DA, Bruera E. Hui D, et al. Lancet Oncol. 2022 Oct;23(10):1321-1331. doi: 10.1016/S1470-2045(22)00508-3. Epub 2022 Sep 7. Lancet Oncol. 2022. PMID: 36087590 Free PMC article. Clinical Trial.
Dexamethasone for cancer-related dyspnoea.
Nishimura R, Ishiki H, Sato J, Satomi E. Nishimura R, et al. Lancet Oncol. 2022 Dec;23(12):e525. doi: 10.1016/S1470-2045(22)00657-X. Lancet Oncol. 2022. PMID: 36455574 No abstract available.